#ublituximab

[reportwire]

New MS Treatment Shows Promise in Trial

New MS Treatment Shows Promise in Trial

2022-08-25 13:20:51 By Amy Norton HealthDay Reporter THURSDAY, Aug. 25, 2022 (HealthDay News) — An experimental antibody therapy for multiple sclerosis can cut symptom flare-ups by half, versus a standard treatment, a new clinical trial has found. The drug, called ublituximab, beat a standard oral medication for MS in reducing patients’ relapses — periods of new or worsening symptoms. It also…

View On WordPress

[joseywritesng]

New MS treatment shows promise in trial

New MS treatment shows promise in trial

By Amy Norton HealthDay Reporter THURSDAY, Aug. 25, 2022 (HealthDay News) — An experimental antibody therapy for multiple sclerosis may cut symptom flare-ups by half, compared with standard treatment, a new clinical trial has found. The drug, called ublituximab, beat a standard oral drug for MS in reducing patients’ relapses — periods of new or worsening symptoms. It was also found to be better…

View On WordPress